Hacker News Reader

Comment by rjzzleep | Hacker News Reader

What's the value proposition for investors here? The data they gather from associating the medication to patients?

My guess is telemedicine insurance coverage arbitrage.

Insurance companies reimburse doctors for consulting and prescribing the medication to the patients. For low risk/low effort consultation, like birth control, the doctor can go through more patients via telemedicine than having them come into the office with similar reimbursement rate as traditional visit.

Rightly or wrongly, I always felt like getting a Pap smear was part of the "deal" when it came to getting a birth control prescription. So it is surprising to me that Nurx can/will (I assume) give you a prescription without having a recent exam.

Yep. States are moving toward an easier process of receiving birth control.

It's not like getting a cervical exam isn't totally sensible for women having unprotected sex, which is often an of those taking birth control pills.

Presumably the company will want to make a profit by billing the health insurance company (or customer, if they don't have one), and the investors will want a slice of those profits.

Their FAQ says they're HIPAA-compliant, and data collected about a patient's health is extremely confidential.

I am an investor in the company. Yes this correct, there will be a cut from the health insurance company. Gradually the company will add more RXs with higher margins.

Reply on news.ycombinator.com